Scientists have discovered the fastest way to identify potent, neutralizing human monoclonal antibodies against SARS-CoV-2, the virus that causes COVID-19. The method -- as well as a trio of successful animal studies on an antibody called 'Ab1' -- are described today in a new study. Ab1 is on track for human clinical trials by early next year.
from Latest Science News -- ScienceDaily https://ift.tt/2TRb053
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment